222 related articles for article (PubMed ID: 26596284)
1. CDKN2B Regulates TGFβ Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels.
Nanda V; Downing KP; Ye J; Xiao S; Kojima Y; Spin JM; DiRenzo D; Nead KT; Connolly AJ; Dandona S; Perisic L; Hedin U; Maegdefessel L; Dalman J; Guo L; Zhao X; Kolodgie FD; Virmani R; Davis HR; Leeper NJ
Circ Res; 2016 Jan; 118(2):230-40. PubMed ID: 26596284
[TBL] [Abstract][Full Text] [Related]
2. Deficient CDKN2B Expression: A Double Hit for PAD.
Hess DL; Annex BH
Circ Res; 2016 Jan; 118(2):190-2. PubMed ID: 26838310
[No Abstract] [Full Text] [Related]
3. Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.
Kojima Y; Downing K; Kundu R; Miller C; Dewey F; Lancero H; Raaz U; Perisic L; Hedin U; Schadt E; Maegdefessel L; Quertermous T; Leeper NJ
J Clin Invest; 2014 Mar; 124(3):1083-97. PubMed ID: 24531546
[TBL] [Abstract][Full Text] [Related]
4. Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation.
Leeper NJ; Raiesdana A; Kojima Y; Kundu RK; Cheng H; Maegdefessel L; Toh R; Ahn GO; Ali ZA; Anderson DR; Miller CL; Roberts SC; Spin JM; de Almeida PE; Wu JC; Xu B; Cheng K; Quertermous M; Kundu S; Kortekaas KE; Berzin E; Downing KP; Dalman RL; Tsao PS; Schadt EE; Owens GK; Quertermous T
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):e1-e10. PubMed ID: 23162013
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B.
Congrains A; Kamide K; Oguro R; Yasuda O; Miyata K; Yamamoto E; Kawai T; Kusunoki H; Yamamoto H; Takeya Y; Yamamoto K; Onishi M; Sugimoto K; Katsuya T; Awata N; Ikebe K; Gondo Y; Oike Y; Ohishi M; Rakugi H
Atherosclerosis; 2012 Feb; 220(2):449-55. PubMed ID: 22178423
[TBL] [Abstract][Full Text] [Related]
6. Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells.
Motterle A; Pu X; Wood H; Xiao Q; Gor S; Ng FL; Chan K; Cross F; Shohreh B; Poston RN; Tucker AT; Caulfield MJ; Ye S
Hum Mol Genet; 2012 Sep; 21(18):4021-9. PubMed ID: 22706276
[TBL] [Abstract][Full Text] [Related]
7. 9p21.3 Coronary Artery Disease Risk Variants Disrupt TEAD Transcription Factor-Dependent Transforming Growth Factor β Regulation of p16 Expression in Human Aortic Smooth Muscle Cells.
Almontashiri NA; Antoine D; Zhou X; Vilmundarson RO; Zhang SX; Hao KN; Chen HH; Stewart AF
Circulation; 2015 Nov; 132(21):1969-78. PubMed ID: 26487755
[TBL] [Abstract][Full Text] [Related]
8. Interferon-γ activates expression of p15 and p16 regardless of 9p21.3 coronary artery disease risk genotype.
Almontashiri NA; Fan M; Cheng BL; Chen HH; Roberts R; Stewart AF
J Am Coll Cardiol; 2013 Jan; 61(2):143-7. PubMed ID: 23199516
[TBL] [Abstract][Full Text] [Related]
9. Deletion of Methionine Sulfoxide Reductase A Does Not Affect Atherothrombosis but Promotes Neointimal Hyperplasia and Extracellular Signal-Regulated Kinase 1/2 Signaling.
Klutho PJ; Pennington SM; Scott JA; Wilson KM; Gu SX; Doddapattar P; Xie L; Venema AN; Zhu LJ; Chauhan AK; Lentz SR; Grumbach IM
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2594-604. PubMed ID: 26449752
[TBL] [Abstract][Full Text] [Related]
10. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
[TBL] [Abstract][Full Text] [Related]
11. BubR1 insufficiency impairs angiogenesis in aging and in experimental critical limb ischemic mice.
Okadome J; Matsumoto T; Yoshiya K; Matsuda D; Tamada K; Onimaru M; Nakano K; Egashira K; Yonemitsu Y; Maehara Y
J Vasc Surg; 2018 Aug; 68(2):576-586.e1. PubMed ID: 28974341
[TBL] [Abstract][Full Text] [Related]
12. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
[TBL] [Abstract][Full Text] [Related]
13. Regulation of vascular smooth muscle cell calcification by syndecan-4/FGF-2/PKCα signalling and cross-talk with TGFβ.
Borland SJ; Morris TG; Borland SC; Morgan MR; Francis SE; Merry CLR; Canfield AE
Cardiovasc Res; 2017 Nov; 113(13):1639-1652. PubMed ID: 29016732
[TBL] [Abstract][Full Text] [Related]
14. DNA-dependent protein kinase (DNA-PK) permits vascular smooth muscle cell proliferation through phosphorylation of the orphan nuclear receptor NOR1.
Medunjanin S; Daniel JM; Weinert S; Dutzmann J; Burgbacher F; Brecht S; Bruemmer D; Kähne T; Naumann M; Sedding DG; Zuschratter W; Braun-Dullaeus RC
Cardiovasc Res; 2015 Jun; 106(3):488-97. PubMed ID: 25852083
[TBL] [Abstract][Full Text] [Related]
15. Increased arterial blood pressure and vascular remodeling in mice lacking salt-inducible kinase 1 (SIK1).
Bertorello AM; Pires N; Igreja B; Pinho MJ; Vorkapic E; Wågsäter D; Wikström J; Behrendt M; Hamsten A; Eriksson P; Soares-da-Silva P; Brion L
Circ Res; 2015 Feb; 116(4):642-52. PubMed ID: 25556206
[TBL] [Abstract][Full Text] [Related]
16. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between macrophages and smooth muscle cells impairs collagen and metalloprotease synthesis and promotes angiogenesis.
Butoi E; Gan AM; Tucureanu MM; Stan D; Macarie RD; Constantinescu C; Calin M; Simionescu M; Manduteanu I
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1568-78. PubMed ID: 27060293
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus.
Jarinova O; Stewart AF; Roberts R; Wells G; Lau P; Naing T; Buerki C; McLean BW; Cook RC; Parker JS; McPherson R
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1671-7. PubMed ID: 19592466
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
[TBL] [Abstract][Full Text] [Related]
20. Deletion of chromosome 9p21 noncoding cardiovascular risk interval in mice alters Smad2 signaling and promotes vascular aneurysm.
Loinard C; Basatemur G; Masters L; Baker L; Harrison J; Figg N; Vilar J; Sage AP; Mallat Z
Circ Cardiovasc Genet; 2014 Dec; 7(6):799-805. PubMed ID: 25176937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
